Single-dose thymoglobulin induction in living-donor renal transplantation

Annals of Transplantation

Volumn 16, Issue 2, 2011, Pages 50-58

  Schenker, Peter ^a   Öztürk, Arzu ^a   Vonend, Oliver ^b   Krüger, Bernd ^c   Jazra, Martin ^a   Wunsch, Andreas ^a   Krämer, Bernhard K ^c   Viebahn, Richard ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Department of Orthopedic Surgery   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

End stage renal disease; Induction; Living donor; Renal transplantation; Thymoglobulin

Indexed keywords

COTRIMOXAZOLE; GANCICLOVIR; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AGE; ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GENDER; GRAFT SURVIVAL; HLA MATCHING; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; LIVING UNRELATED DONOR; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; POLYOMAVIRUS INFECTION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SURVIVAL;

EID: 79960084370     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.881865     Document Type: Article

References (39)

1. Wolfe RA, Ashby VB, Milford EL et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med, 1999; 341: 1725-30
2. Eurotransplant International Foundation. Annual Report 2009. Available at: http://www.eurotransplant.org/files/annual_report/ar_2009.pdf. Accessed on 17 December 2010
3. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S: High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med, 1995; 333: 333-36
4. Matas AJ, Payne WD, Sutherland DE et al: 2,500 living donor kidney transplants: a single-center experience. Ann Surg, 2001; 234: 149-64
5. Gjertson DW, Cecka JM: Living unrelated donor kidney transplantation. Kidney Int, 2000; 58: 491-99
6. Campbell SB, Hothersall E, Preston J et al: Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants. Transplantation, 2003; 76: 1452-57
7. Lim WH, Chang SH, Coates PT, McDonald SP: Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates. Transplantation, 2007; 84: 972-80
8. Rosenberg JC, Jones B, Oh H: Accelerated rejection following offspring-to-mother and husband-towife transplants. Clin Transplant, 2004; 18: 729-33
9. Ciancio G, Burke GW, Miller J: Induction therapy in renal transplantation: an overview of current developments. Drugs, 2007; 67: 2667-80
10. Knoll G: Trends in kidney transplantation over the past decade. Drugs, 2008; 68(Suppl.1): 3-10
11. Deeks ED, Keating GM: Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs, 2009; 69: 1483-512
12. Axelrod DA, McCullough KP, Brewer ED et al: Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation. Am J Transplant, 2010; 10: 987-1002
13. Mota C, Martins L, Costa T et al: Nineteen years of experience utilizing anti-T-Lymphocyte globulin induction in pediatric kidney transplantation. Ann Transplant, 2010; 15: 84-91
14. Kaden J, May G, Volp A, Wesslau C: Improved longterm survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: a single centre experience. Ann Transplant, 2009; 14: 7-17
15. Noel C, Abramowicz D, Durand D et al: Daclizumab versus antithymocyte globulin in high-immunological- risk renal transplant recipients. J Am Soc Nephrol, 2009; 20: 1385-92
16. Wiland AM, Fink JC, Weir MR et al: Should livingunrelated renal transplant recipients receive antibody induction? Results of a clinical experience trial. Transplantation, 2004; 77: 422-25
17. Brennan DC, Schnitzler MA: Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med, 2008; 359: 1736-38
18. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant, 2009; 9(Suppl.3): S1-155
19. Yarlagadda SG, Coca SG, Formica RN Jr et al: Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant, 2009; 24: 1039-47
20. Narayanan R, Cardella CJ, Cattran DC et al: Delayed graft function and the risk of death with graft function in living donor kidney transplant recipients. Am J Kidney Dis, 2010; 56: 961-70
21. Ojo AO, Wolfe RA, Held PJ et al: Delayed graft function: risk factors and implications for renal allograft survival. Transplantation, 1997; 63: 968-74
22. Goggins WC, Pascual MA, Powelson JA et al: A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation, 2003; 76: 798-802
23. Brennan DC, Flavin K, Lowell JA et al: A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation, 1999; 67: 1011-18
24. Senel FM, Karakayali H, Moray G, Haberal M: Delayed graft function: predictive factors and impact on outcome in living-related kidney transplantations. Ren Fail, 1998; 20: 589-95
25. Hardinger KL, Rasu RS, Skelton R et al: Thymoglobulin induction dosing strategies in a low-risk kidney transplant population: three or four days? J Transplant, 2010; Epub
26. Opelz G, Naujokat C, Daniel V et al: Disassociation between risk of graft loss and risk of non- Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation, 2006; 81: 1227-33
27. Ducloux D, Kazory A, Challier B et al: Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation, 2004; 77: 1029-33
28. Lowell JA, Brennan DC, Shenoy S et al: Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: a 12- year single-center experience. Surgery, 1996; 119: 538-43
29. Simforoosh N, Basiri A, Fattahi MR et al: Living unrelated versus living related kidney transplantation: 20 years' experience with 2155 cases. Transplant Proc, 2006; 38: 422-25
30. Ahmad N, Ahmed K, Khan MS et al: Living-unrelated donor renal transplantation: an alternative to living-related donor transplantation? Ann R Coll Surg Engl, 2008; 90: 247-50
31. OPTN/SRTR Annual Report 2009: Transplant Data 1999-2008. Available from: URL:http: //optn. transplant.hrsa.gov/ar2009/. 2009. Accessed on 10 December 2010
32. Opelz G, Wujciak T, Dohler B et al: HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet, 1999; 1: 334-42
33. Fuller TF, Feng S, Brennan TV et al: Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival. Transplantation, 2004; 78: 1030-35
34. Voiculescu A, Ivens K, Hetzel GR et al: Kidney transplantation from related and unrelated living donors in a single German centre. Nephrol Dial Transplant, 2003; 18: 418-25
35. Lim WH, Chang SH, Chadban SJ et al: Interleukin-2 receptor antibody reduces rejection rates and graft loss in live-donor kidney transplant recipients. Transplantation, 2009; 88: 1208-13
36. Hardinger KL, Schnitzler MA, Koch MJ et al: Thymoglobulin induction is safe and effective in livedonor renal transplantation: a single center experience. Transplantation, 2006; 81: 1285-89
37. Ciancio G, Gaynor JJ, Roth D et al: Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation. Transplant Proc, 2010; 42: 3503-6
38. Tan HP, Kaczorowski D, Basu A et al: Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation. Transplant Proc, 2005; 37: 4235-40
39. Gaber AO, Knight RJ, Patel S, Gaber LW: A review of the evidence for use of thymoglobulin induction in renal transplantation. Transplant Proc, 2010; 42: 1395-400